US 8101186
Peptides that block the binding of IgG to FcRn
granted A61KA61K38/00A61P
Quick answer
US patent 8101186 (Peptides that block the binding of IgG to FcRn) held by Syntonix Pharmaceuticals, Inc. expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Syntonix Pharmaceuticals, Inc.
- Grant date
- Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K38/00, A61P, A61P1/00, A61P1/04